SunTrust Starts Otonomy (OTIC) at Buy
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/20/2026
- Wall St indexes fall to two-week lows as rising bond yields, disappointing Walmart results drag
- Walmart shares fall despite earnings beat
- Alibaba stock dips as Q2 profit misses estimates despite strong AI cloud growth
- Wolfe remains "broadly bullish on AI semis stocks", names Top Pick
- Moderna stock pulls back after massive one-day rally: analysts weigh in
- Marvell issues Google warrant tied to custom chip deal
- FOMC minutes from July 28-29th meeting
- US stock futures steady after tech slump; investors focus on Middle East tensions
- Lowe's Cos. (LOW) Tops Q2 EPS by 17c, Misses on Revenue; Offers Fy27 Guidance
- Deutsche Bank calls Treasury buyback doubling similar to ’operation twist’
UPDATE: Cowen Starts Otonomy (OTIC) at Outperform
February 4, 2015 7:12 AM EST(Updated - February 4, 2015 9:18 AM EST)
Cowen initiated coverage on Otonomy (NASDAQ: OTIC) with an Outperform rating and a price target of $55.00. Analyst Ken Cacciatore thinks its technology for ear disorders will create "significant value."
"Our rating is predicated on... More
